Cargando…
Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
Autores principales: | Ahmed, Faria, Jo, Dong-Hyeon, Lee, Seung-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750385/ https://www.ncbi.nlm.nih.gov/pubmed/33365027 http://dx.doi.org/10.3389/fimmu.2020.586765 |
Ejemplares similares
-
The Natural Killer–Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
por: Peterson, Erin E., et al.
Publicado: (2021) -
Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy
por: Wu, Feifeng, et al.
Publicado: (2021) -
Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017) -
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
por: Di Vito, Clara, et al.
Publicado: (2022) -
Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG
por: Esteso, Gloria, et al.
Publicado: (2021)